scholarly article | Q13442814 |
P356 | DOI | 10.1200/JCO.2005.02.4950 |
P698 | PubMed publication ID | 16145064 |
P50 | author | Kenneth C. Anderson | Q28421846 |
P2093 | author name string | Ann T Farrell | |
Richard Pazdur | |||
P433 | issue | 28 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 7207-7211 | |
P577 | publication date | 2005-09-06 | |
P1433 | published in | Journal of Clinical Oncology | Q400292 |
P1476 | title | Development of effective new treatments for multiple myeloma | |
P478 | volume | 23 |
Q81527272 | Clinically relevant end points and new drug approvals for myeloma |
Q36589122 | Combination chemotherapy increases cytotoxicity of multiple myeloma cells by modification of nuclear factor (NF)-κB activity |
Q36447976 | Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARgamma cross talk with NF-kappaB and C/EBP |
Q58415971 | Low-dose vs. high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myélome |
Q38583915 | Response to dexamethasone is glucose-sensitive in multiple myeloma cell lines |
Q36709283 | The 39th David A. Karnofsky Lecture: bench-to-bedside translation of targeted therapies in multiple myeloma |
Search more.